Cervical cancer trends related to mortality in Japan

Journal of the Turkish German Gynecology Association

Volumn 7, Issue 4, 2006, Pages 292-296

  Aoki, Kazuo ^a   Misumi, Junichi ^a   Wang, Jianru ^b   Jiang, Hengli ^b   Sun, Juan ^c  

^a OITA UNIVERSITY   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Cervix uteri; Life expectancy; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; HUMAN; JAPAN; LIFE EXPECTANCY; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER;

EID: 33846389146     PISSN: 13090399     EISSN: 13090380     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Stanley K, Stjernsward J, Koroltchouk V. Women and cancer. World Health Stat Q 1987;40:267-78.
2. Aleknaviciene B, Smailyte G, Elaawar B, Kurtinaitis J. Cervical cancer: recent trends of incidence and mortality in Lithuania. Medicina (Kaunas) 2002;38:223-30.
3. Sierra R, Parkin DM, Leiva GM. Cancer in Costa Rica. Cancer Res 1989; 49:717-24.
4. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:904-8.
5. Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer 2000;36:2266-71.
6. Ministry of Health, Labor, and Welfare of Japan. The 2005 edition of abridged life table in Japan, announced in 25 July, 2006.
7. Ministry of Health, Labor, and Welfare of Japan. Round numbers in the 2005 edition of Vital Statistics in Japan, announced in 24 July, 2006.
8. Nomura K (Editor in chief). Cancer Statistics in Japan 2005 Tokyo: Foundation for promotion of cancer Research (FPCR), 2005.
9. Tominaga S. Cancer of the Japanese, from the view point of epidemiology. Gan To Kagaku Ryoho 1984;11:688-95. (in Japanese with English Abstract)
10. Llorca J, Prieto MD, Delgado-Rodriguez M. Increase in cervical cancer mortality in Spain 1951-1991. J Epidemiol Community Health 1999;53:408-11.
11. Kono A, Sun J, Misumi J. The time trend of breast cancer mortality in Japan. Arch Gynecol Obstet 2005;272:187-90.
12. Sun J, Kono A, Sun P, Misumi J. Population characteristics of traffic accident-related deaths in Japan and Ireland, 1950-2000. J Emerg Med 2004;27:333-8.
13. Sun J, Sun P. The impact of uterine cancer on life expectancy in Japan. Int J Gynecol Obstet 2004;86:54-5.
14. Kato I, Tominaga S, Kuroishi T. The epidemiology of cancers of the female genital organs. Gan No Rinsho 1989;35:1-8.
15. Sun J, Misumi J, Shimaoka A et al. Stomach cancer-related mortality rate is higher in young Japanese women than in men. Public Health 2002;116:39-44.
16. Sun J, Misumi J, Shimaoka A et al. Stomach cancer mortality. Eur J Cancer Prev 2001;10:61-7.
17. Liu S, Semenciw R, Probert A, Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001;11:24-31.
18. Akaza H, Tsuruo T, Saijo N et al. Cancer screening. Gan To Kagaku Ryoho 2005;32:125-34. (in Japanese with English Abstract).
19. Sobue T. et al. A case-control study of the effectiveness of cervical cancer screening in Osaka; Japan. Jpn J Cancer Res 1988;79:1269-75.
20. Hisamichi S. Evaluation of effectiveness for new method on cancel-screening. Tokyo: Japan Public Health Association; 2001 (in Japanese).
21. The Research Group for Population-based Cancer Registry in Japan. Cancer incidence and incidence rates in Japan in 1999: Estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2004;34:352-6.
22. Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
23. Munoz N, Bosch FX, de Sanjose S et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
24. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
25. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006; 208:152-64.
26. Zheng PS, Iwasaka T, Zhang ZM et al. Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses. Gynecol Oncol 2000;77:394-8.
27. Steckley SL, Pickworth WB, Haverkos HW. Cigarette smoking and cervical cancer. Part II: a geographic variability study. Biomed Pharmacother. 2003;57:78-83. Erratum in: Biomed Pharmacother 2003;57:377.
28. Karube A, Sasaki M, Tanaka H et al. Human papilloma virus type 16 infection and the early onset of cervical cancer. Biochem Biophys Res Commun 2004;323:621-4.
29. Masumoto N, Fujii T, Ishikawa M et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients. Gynecol Oncol 2004;94:509-14.